How much cash does Niagen Bioscience, Inc. Common Stock generate?

Niagen Bioscience, Inc. Common Stock (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.

Where does Niagen Bioscience, Inc. Common Stock's cash flow data come from?

Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Niagen Bioscience, Inc. Common Stock NAGE Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23
Net income	$17.38M+103%	$8.55M+269%	-$5.05M—
Depreciation and amortization	$612K-7.7%	$663K-23.8%	$870K—
Stock-based compensation	$6.07M+65.9%	$3.66M-23.0%	$4.75M—
Net cash from operating activities	$13.5M+9.1%	$12.37M+73.9%	$7.12M—
Net cash from investing activities	-$292K-104%	-$143K0.0%	-$143K—
Repurchases of common stock	——	$0—	——
Net cash from financing activities	$7M+30.3%	$5.37M+6,066%	-$90K—
Net increase (decrease) in cash	$20.13M+16.1%	$17.34M+152%	$6.88M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Niagen Bioscience, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Niagen Bioscience, Inc. Common Stock generate?: Niagen Bioscience, Inc. Common Stock (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.
Where does Niagen Bioscience, Inc. Common Stock's cash flow data come from?: Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.